Skip to content

Clinical trials

Phase 1/2 Colonic Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Colonic Neoplasms Phase: Phase 1/2 Country / region: United States Clear all

109 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20006
20015
20022
20046
20052
20063
20074
20082
20091
20105
20111
20125
20134
20151
20162
20176
20186
20199
20205
20213
20224
20237
20243
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed57
Terminated16
Recruiting13
Active, not recruiting13
Unknown status5
Withdrawn3
Suspended2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)12
M.D. Anderson Cancer Center4
Memorial Sloan Kettering Cancer Center4
Gilead Sciences3
Northwestern University3
Roswell Park Cancer Institute3
A2 Biotherapeutics Inc.2
City of Hope Medical Center2
Eli Lilly and Company2
GlaxoSmithKline2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Colonic Neoplasms109
Colorectal Neoplasms61
Rectal Neoplasms57
Pancreatic Neoplasms35
Breast Neoplasms23
Neoplasm Metastasis23
Lung Neoplasms21
Carcinoma, Non-Small-Cell Lung20
Neoplasms20
Head and Neck Neoplasms17

Trials

Showing 1 to 25 of 109. Each trial links to its page on Pharma Observatory.

9 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.